Allozyne
Allozyne is a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current stan
Allozyne
Allozyne is a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current stan
has abstract
Allozyne is a clinical stage b ...... ransaction were not disclosed.
@en
founding year
location city
type
Link from a Wikipage to an external page
Wikipage page ID
27,932,300
Wikipage revision ID
737,200,599
image caption
Allozyne facility in the Eastlake neighborhood of Seattle
location country
Slogan
Emerging Technologies in Protein Therapeutics
hypernym
point
47.63415 -122.326789
comment
Allozyne is a clinical stage b ...... y compared to the current stan
@en
label
Allozyne
@en
lat
4.763415e+1
long
-1.22326789e+2
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Allozyne Inc.
@en